ARIAD Announces Issuance of Key U.S. Patent on Brigatinib
Go back to ARIAD Announces Issuance of Key U.S. Patent on Brigatinib| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 24.94 -0.15 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.09 | 52 Week High | $14.34 | |||
| Open | $24.94 | 52 Week Low | $4.37 | |||
| Day High | $24.94 | P/E | N/A | |||
| Day Low | $24.94 | EPS | $-1.45 | |||
| Volume | 14 | |||||
